Priming with a “simplified regimen” of HIV-1 DNA vaccine is as good as a “standard regimen” when boosted with heterologous HIV-1 MVA vaccine

समान संसाधन

• Priming with a Simplified Intradermal HIV-1 DNA Vaccine Regimen followed by Boosting with Recombinant HIV-1 MVA Vaccine Is Safe and Immunogenic: A Phase IIa Randomized Clinical Trial
  द्वारा: Munseri, Patricia. J., और अन्य
  प्रकाशित: (2015)
• Priming with a simplified intradermal HIV-1 DNA vaccine regimen followed by boosting with recombinant HIV-1 MVA vaccine is safe and immunogenic: a phase IIa randomized clinical trial.
  द्वारा: Patricia J Munseri, और अन्य
  प्रकाशित: (2015-01-01)
• Preferential Targeting of Conserved Gag Regions after Vaccination with a Heterologous DNA Prime-Modified Vaccinia Virus Ankara Boost HIV-1 Vaccine Regimen
  द्वारा: Bauer, Asli, और अन्य
  प्रकाशित: (2017)
• Breadth, phenotype and functionality of Gag-specific T cell responses induced by a heterologous DNA/MVA prime-boost HIV-1 vaccine regimen
  द्वारा: Podola, L, और अन्य
  प्रकाशित: (2012)
• High prevalence of ECG variations and abnormalities in young and healthy TaMoVac 01 HIV vaccine trial volunteers from Tanzania
  द्वारा: Mann, PJ, और अन्य
  प्रकाशित: (2012)